Skip to main content
BIOMERICA INC logo

BIOMERICA INC — Investor Relations & Filings

Ticker · BMRA ISIN · US09061H3075 US Manufacturing
Open in API
Filings indexed 587 across all filing types
Latest filing 2024-12-17 Director's Dealing
Country US United States of America
Listing US BMRA

About BIOMERICA INC

https://biomerica.com/

Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced in-vitro diagnostic (IVD) and therapeutic products. The company provides solutions for both laboratory and at-home testing, designed for the early detection and monitoring of chronic conditions. Its primary research and development focus is on gastrointestinal and inflammatory diseases, with a notable pipeline that includes a non-drug, diagnostic-guided therapy for Irritable Bowel Syndrome (IBS). Biomerica's products aim to enhance patient health and well-being while contributing to the reduction of total healthcare costs.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-12-17 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 13, 2024, reporting the submission of matters to a vote of security holders at the company's 2024 Annual Meeting. It details the voting results for multiple proposals including election of directors, advisory vote on executive compensation, ratification of auditors, stock incentive plan approval, amendments to the certificate of incorporation, and adjournment approval. The content is focused on official voting results from a shareholder meeting, which matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 5918 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the classification is DVA with high confidence.
2024-12-17 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Biomerica, Inc. It registers shares under a stock incentive plan. The text includes references to the Securities Act of 1933, details about the stock plan, indemnification provisions, and incorporation by reference of other filings such as the 10-K and 10-Q. Form S-8 is a registration statement for securities to be offered to employees and is not a financial report, earnings release, or management discussion. It is a capital markets filing related to securities registration and issuance under an employee stock plan. This fits best under Capital/Financing Update (CAP) as it relates to registration of shares for issuance under a stock incentive plan, which is a capital structure change and financing activity. The document length and content confirm it is the registration statement itself, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2024-11-25 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-14 English
Delisting Announcement 2024
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 6, 2024, by Biomerica, Inc. The key content is under Item 3.01, which is a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. It discusses the company's non-compliance with Nasdaq's minimum bid price requirement and the extension granted to regain compliance. The document is a current report notifying the market about the delisting risk and related Nasdaq communications. This matches the definition of a Delisting Announcement (DLST). The document length is about 4988 characters, which is sufficient to contain substantive information rather than just a brief announcement. Therefore, the correct classification is DLST with high confidence.
2024-11-06 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Q1 2025
2024-10-15 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.